Intersubject and dose‐related variability after intravenous administration of erythromycin.

KL Austin; LE Mather; CR Philpot; PJ McDonald

doi:10.1111/j.1365-2125.1980.tb01755.x

Intersubject and dose‐related variability after intravenous administration of erythromycin.

KL Austin, LE Mather, CR Philpot, PJ McDonald

Research output: Contribution to journal › Article › peer-review

101 Citations (Scopus)

Abstract

1 It is well‐known that considerable variability and unpredictability in serum concentrations results from orally administered erythromycin. 2 Disposition kinetics and their variability were studies in 24 healthy subjects after a single dose of erythromycin lactobionate and four doses were studied to evaluate dose‐related variability in five other subjects. 3 Erythromycin kinetics were adequately described by a classical two compartment open model with little intersubject variability. 4 Dose‐related variability occurred. Clearance was independent of dose but T1/2 beta and Vdss increased with dose. 5 Data are presented to show that non‐invasive sampling of urine and saliva are of limited value in studying erythromycin pharmacokinetics. 1980 The British Pharmacological Society

Original language	English
Pages (from-to)	273-279
Number of pages	7
Journal	British Journal of Clinical Pharmacology
Volume	10
Issue number	3
DOIs	https://doi.org/10.1111/j.1365-2125.1980.tb01755.x
Publication status	Published - Sept 1980

Access to Document

10.1111/j.1365-2125.1980.tb01755.xLicence: In Copyright

Cite this

@article{d865c14145b34225a56d1f745f715308,

title = "Intersubject and dose‐related variability after intravenous administration of erythromycin.",

abstract = "1 It is well‐known that considerable variability and unpredictability in serum concentrations results from orally administered erythromycin. 2 Disposition kinetics and their variability were studies in 24 healthy subjects after a single dose of erythromycin lactobionate and four doses were studied to evaluate dose‐related variability in five other subjects. 3 Erythromycin kinetics were adequately described by a classical two compartment open model with little intersubject variability. 4 Dose‐related variability occurred. Clearance was independent of dose but T1/2 beta and Vdss increased with dose. 5 Data are presented to show that non‐invasive sampling of urine and saliva are of limited value in studying erythromycin pharmacokinetics. 1980 The British Pharmacological Society",

author = "KL Austin and LE Mather and CR Philpot and PJ McDonald",

year = "1980",

month = sep,

doi = "10.1111/j.1365-2125.1980.tb01755.x",

language = "English",

volume = "10",

pages = "273--279",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Intersubject and dose‐related variability after intravenous administration of erythromycin.

AU - Austin, KL

AU - Mather, LE

AU - Philpot, CR

AU - McDonald, PJ

PY - 1980/9

Y1 - 1980/9

N2 - 1 It is well‐known that considerable variability and unpredictability in serum concentrations results from orally administered erythromycin. 2 Disposition kinetics and their variability were studies in 24 healthy subjects after a single dose of erythromycin lactobionate and four doses were studied to evaluate dose‐related variability in five other subjects. 3 Erythromycin kinetics were adequately described by a classical two compartment open model with little intersubject variability. 4 Dose‐related variability occurred. Clearance was independent of dose but T1/2 beta and Vdss increased with dose. 5 Data are presented to show that non‐invasive sampling of urine and saliva are of limited value in studying erythromycin pharmacokinetics. 1980 The British Pharmacological Society

AB - 1 It is well‐known that considerable variability and unpredictability in serum concentrations results from orally administered erythromycin. 2 Disposition kinetics and their variability were studies in 24 healthy subjects after a single dose of erythromycin lactobionate and four doses were studied to evaluate dose‐related variability in five other subjects. 3 Erythromycin kinetics were adequately described by a classical two compartment open model with little intersubject variability. 4 Dose‐related variability occurred. Clearance was independent of dose but T1/2 beta and Vdss increased with dose. 5 Data are presented to show that non‐invasive sampling of urine and saliva are of limited value in studying erythromycin pharmacokinetics. 1980 The British Pharmacological Society

UR - http://www.scopus.com/inward/record.url?scp=0018868749&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.1980.tb01755.x

DO - 10.1111/j.1365-2125.1980.tb01755.x

M3 - Article

C2 - 7437245

AN - SCOPUS:0018868749

SN - 0306-5251

VL - 10

SP - 273

EP - 279

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 3

ER -

Intersubject and dose‐related variability after intravenous administration of erythromycin.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this